Evidence map›Paper›PMID 36076846›Full record

ArticleFoods (Basel, Switzerland)2022

Production of Xylooligosaccharides from

Liqin Qin, Jinghao Ma, Huafeng Tian, Yanli Ma, Qiuhua Wu, Shuang Cheng, Guangsen Fan

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liqin QinSchool of Food and Health, Beijing Technology and Business University (BTBU), Beijing 100048, China.
Jinghao MaSchool of Food and Health, Beijing Technology and Business University (BTBU), Beijing 100048, China.
Huafeng TianCollege of Chemistry and Materials Engineering, Beijing Technology & Business University (BTBU), Beijing 100048, China.
Yanli MaHenan Key Laboratory of Industrial Microbial Resources and Fermentation Technology, Nanyang Institute of Technology, Nanyang 473004, China.
Qiuhua WuSchool of Food and Health, Beijing Technology and Business University (BTBU), Beijing 100048, China.
Shuang ChengHenan Key Laboratory of Industrial Microbial Resources and Fermentation Technology, Nanyang Institute of Technology, Nanyang 473004, China.
Guangsen FanSchool of Food and Health, Beijing Technology and Business University (BTBU), Beijing 100048, China.ORCID 0000-0001-5758-130X

Funding

the Beijing Natural Science Foundation 2202014the Beijing Natural Science Foundation 6164029the Beijing Natural Science Foundation 6222003the General Project of Scientific Research Program of Beijing Municipal Education Commission KM201910011006/PXM2019_014213_000007the Open Research Fund Program of Henan Key Laboratory of Industrial Microbial Resources and Fermentation Technology HIMFT20190205the School Level Cultivation Fund of Beijing Technology and Business University for Distinguished and Excellent Young Scholars BTBUYP2021
6 · The paper itself

Abstract

The production of xylooligosaccharides (XOS) from Jiuzao was studied using a two-stage process based on autohydrolysis pretreatment followed by enzymatic hydrolysis. Jiuzao was autohydrolyzed under conditions where temperature, time, particle size, and solid-liquid ratio were varied experimentally. Optimal XOS production was obtained from Jiuzao with a >20 mesh particle size treated at 181.5 °C for 20 min with a 1:13.6 solid-liquid ratio. Subsequently, optimal enzymatic hydrolysis conditions for xylanase XynAR were identified as 60 °C, pH 5, and xylanase XynAR loading of 15 U/mL. Using these conditions, a yield of 34.2% XOS was obtained from Jiuzao within 2 h. The process developed in the present study could enable effective and ecofriendly industrial production of XOS from Jiuzao.

Indexed as

autohydrolysisenzymatic hydrolysisJiuzaothermostable xylanasexylooligosaccharides

Identifiers

PMID36076846
PMCPMC9455638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.